National Cancer Center, Korea

This study is testing whether the drug lurbinectedin can help control high-grade pancreatic neuroendocrine tumors when standard treatments have stopped working. The trial will enroll 46 patients who have already tried other cancer therapies. Researchers will measure how well the …

This study is for women whose ovarian cancer has returned and stopped responding to standard platinum chemotherapy. It aims to see if a major surgery to remove visible tumors, followed by a heated chemotherapy solution washed directly inside the abdomen, helps patients live longe…

This study is testing whether a combination of two drugs, pembrolizumab (given by IV) and lenvatinib (taken as a pill), can help control advanced adrenal cancer that has continued to grow despite standard chemotherapy. It will involve about 30 adult patients who have already trie…

This study is creating a large national registry of pancreatic cancer patients to collect real-world information on how the disease is treated and how patients fare over time. It will analyze past medical records from 2010 onward and follow over 800 new patients through 2029. The…